Royalty Pharma Other Operating Income or Expenses 2019-2024 | RPRX

Royalty Pharma other operating income or expenses for the twelve months ending September 30, 2024 were $-0.492B, a 68.5% decline year-over-year.

  • Royalty Pharma annual other operating income or expenses for 2023 were $-0.561B, a 63.12% decline from 2022.
  • Royalty Pharma annual other operating income or expenses for 2022 were $-1.52B, a 235.67% increase from 2021.
  • Royalty Pharma annual other operating income or expenses for 2021 were $-0.453B, a 53.04% increase from 2020.

Royalty Pharma Other Operating Income or Expenses 2019-2024 | RPRX

  • Royalty Pharma annual other operating income or expenses for 2023 were $-0.561B, a 63.12% decline from 2022.
  • Royalty Pharma annual other operating income or expenses for 2022 were $-1.52B, a 235.67% increase from 2021.
  • Royalty Pharma annual other operating income or expenses for 2021 were $-0.453B, a 53.04% increase from 2020.